Plasmodium Knowlesi Apical Membrane Antigen 1 Gene
Total Page:16
File Type:pdf, Size:1020Kb
Low levels of polymorphisms and no evidence for diversifying selection on the Plasmodium knowlesi Apical Membrane Antigen 1 gene. Bart W Faber, Khamisah Abdul Kadir, Roberto Rodriguez-Garcia, Edmond J Remarque, Frederick A Saul, Brigitte Vulliez-Le Normand, Graham A Bentley, Clemens H M Kocken, Balbir Singh To cite this version: Bart W Faber, Khamisah Abdul Kadir, Roberto Rodriguez-Garcia, Edmond J Remarque, Frederick A Saul, et al.. Low levels of polymorphisms and no evidence for diversifying selection on the Plasmodium knowlesi Apical Membrane Antigen 1 gene.. PLoS ONE, Public Library of Science, 2015, 10 (4), pp.e0124400. 10.1371/journal.pone.0124400. pasteur-01256155 HAL Id: pasteur-01256155 https://hal-pasteur.archives-ouvertes.fr/pasteur-01256155 Submitted on 14 Jan 2016 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Distributed under a Creative Commons Attribution| 4.0 International License RESEARCH ARTICLE Low Levels of Polymorphisms and No Evidence for Diversifying Selection on the Plasmodium knowlesi Apical Membrane Antigen 1 Gene Bart W. Faber1*, Khamisah Abdul Kadir2, Roberto Rodriguez-Garcia1, Edmond J Remarque1, Frederick A. Saul3,4¤a, Brigitte Vulliez-Le Normand3,4¤b, Graham A. Bentley3,4¤c, Clemens H. M. Kocken1, Balbir Singh2* 1 Department of Parasitology, Biomedical Primate Research Centre, Rijswijk, The Netherlands, 2 Malaria Research Centre, Faculty of Medicine and Health Sciences, Universiti Malaysia Sarawak, Kuching, Sarawak, Malaysia, 3 Institut Pasteur, Unité d’Immunologie Structurale, Département de Biologie Structurale et Chimie, Paris, France, 4 CNRS URA 2185, Paris, France ¤a Current address: Institut Pasteur, Plate-forme de Cristallographie, Département de Biologie Structurale et Chimie, CNRS UMR 3528, Paris, France ¤b Current address: Institut Pasteur, Unité de Microbiologie Structurale, Département de Biologie OPEN ACCESS Structurale et Chimie, CNRS UMR 3528, Université Paris Diderot, Sorbonne Paris Cité, Microbiologie Citation: Faber BW, Abdul Kadir K, Rodriguez- Structurale, Paris, France ¤ Garcia R, Remarque EJ, Saul FA, Vulliez-Le c Current address: Institut Pasteur, Paris, France * [email protected] (BWF); [email protected] (BS) Normand B, et al. (2015) Low Levels of Polymorphisms and No Evidence for Diversifying Selection on the Plasmodium knowlesi Apical Membrane Antigen 1 Gene. PLoS ONE 10(4): Abstract e0124400. doi:10.1371/journal.pone.0124400 Academic Editor: Georges Snounou, Université Infection with Plasmodium knowlesi, a zoonotic primate malaria, is a growing human health Pierre et Marie Curie, FRANCE problem in Southeast Asia. P. knowlesi is being used in malaria vaccine studies, and a num- Received: December 23, 2014 ber of proteins are being considered as candidate malaria vaccine antigens, including the Apical Membrane Antigen 1 (AMA1). In order to determine genetic diversity of the ama1 Accepted: March 3, 2015 gene and to identify epitopes of AMA1 under strongest immune selection, the ama1 gene of Published: April 16, 2015 52 P. knowlesi isolates derived from human infections was sequenced. Sequence analysis Copyright: © 2015 Faber et al. This is an open of isolates from two geographically isolated regions in Sarawak showed that polymorphism access article distributed under the terms of the in the protein is low compared to that of AMA1 of the major human malaria parasites, P. fal- Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any ciparum and P. vivax. Although the number of haplotypes was 27, the frequency of muta- medium, provided the original author and source are tions at the majority of the polymorphic positions was low, and only six positions had a credited. variance frequency higher than 10%. Only two positions had more than one alternative Data Availability Statement: Sequence data are amino acid. Interestingly, three of the high-frequency polymorphic sites correspond to in- deposited at the Genbank repository, under variant sites in PfAMA1 or PvAMA1. Statistically significant differences in the quantity of accession numbers KP067834 to KP067885. three of the six high frequency mutations were observed between the two regions. These Funding: This work was supported by: European analyses suggest that the pkama1 gene is not under balancing selection, as observed for Commission EUROMALVAC2 (contract QLK2-CT- pfama1 pvama1 2002-01197), The Centre National de la Recherche and , and that the PkAMA1 protein is not a primary target for protective hu- Scientifique, The Universiti Malaysia Sarawak (grant moral immune responses in their reservoir macaque hosts, unlike PfAMA1 and PvAMA1 in number 01(TD03)/1003/2013(01)), European humans. The low level of polymorphism justifies the development of a single allele Commission EMVDA grant LSHP-CT-2007-037506, PkAMA1-based vaccine. E(M)VI, The European (Malaria) Vaccine Initiative, and Universiti of Sarawak: Grant E14054/F05/54/PKI/ PLOS ONE | DOI:10.1371/journal.pone.0124400 April 16, 2015 1/11 Polymorphisms and Selection on the PkAMA1 Gene 09/2012(01); www.emvda.org; www.euvaccine.eu; Introduction www.evimalar.org; ec.europa.eu/research/health/ Plasmodium infectious-diseases/poverty-diseases/projects/71_en. In the last decade it has become increasingly clear that the simian malaria parasite, htm. The external funders had no role in study knowlesi, is widely distributed in Southeast Asia and can cause severe disease and death in hu- design, data collection and analysis, decision to mans [1,2]. Its distribution coincides largely with the distribution of its natural hosts, the long- publish, or preparation of the manuscript. tailed and pig-tailed macaques, and the Anopheline vectors belonging to the Anopheles leuco- Competing Interests: The authors have declared sphyrus group [1]. P. knowlesi infections in humans were overlooked for a long time as they that no competing interests exist. were misdiagnosed by microscopy as the morphologically similar P. malariae [2]. Today, P. knowlesi is considered a serious threat, responsible for approximately 66% of all hospitalized malaria cases for the year 2013 in Malaysian Borneo [3]. Although P. knowlesi is an ancient parasite that has been infecting humans for a long time [4], such infections are considered to be primarily a zoonotic event. There are no biological barriers that would prevent transmission by mosquitoes from macaques to humans and from humans to humans, and this has been demonstrated under laboratory conditions [5]. The distribution and magnitude of infections by P. knowlesi warrants the development of a vaccine against P. knowlesi. Apical Membrane Antigen 1 (AMA1) is a promising vaccine candi- date (reviewed in [6]). A recent vaccination trial with rhesus monkeys using heterologously ex- pressed P. knowlesi AMA1 (PkAMA1) showed that, after two booster immunizations, five out of six animals were able to control the parasitemia [7]. P. falciparum and P. vivax AMA1 are highly polymorphic molecules, requiring the develop- ment of vaccine strategies to overcome the diversity [8–12]. In order to determine genetic di- versity of the ama1 gene and to identify epitopes on AMA1 under strongest immune selection, the ama1 gene of 52 P. knowlesi isolates derived from human infections was sequenced and analysed. Methods Sample collection: Blood samples were collected from Plasmodium knowlesi malaria patients at Kapit Hospital and Betong Hospital, Sarawak, Malaysia, after written informed consent was obtained. The distance between Kapit Hospital and Betong Hospital is 233 km. This study was approved by the Medical Ethics Committee of Universiti Malaysia Sarawak. DNA was ex- tracted from the blood samples using the QIAamp DNA Blood Midi Kit (Qiagen, Germany). The P. knowlesi ama1 gene was amplified from 65 samples using primers 2334F, GCTACCTG AACTCGGTTGCTA (starting 102 bp upstream from the start codon ATG) and 2335R, ACACCCACAGTTGTTACGACC (ending 57 bp after the stop codon). PCR amplifica- tion was undertaken with the Phusion High-Fidelity DNA Polymerase PCR Kit (Thermo Sci- entific, USA). Amplification was for 35 rounds, with denaturing at 98°C for 7 s, annealing at 63°C for 20 s and elongation at 72°C for 52 s. PCR products were purified using Gel/PCR DNA Fragment Extraction kit (Geneaid, Taiwan) and eluted using 20 μl of elution buffer. The same primers were used for sequencing the full-length pkama1 coding region. Addi- tionally, internal primers 2371F, GGTCCACGATAC and 2370R, TGGTTGATCTGAAGCGCT were used. The latter primers were designed based on preliminary sequencing results which showed that these parts of the gene were fully conserved. Sequencing was performed by Base- clear, Leiden, The Netherlands. Sequences were deposited in the Genbank database [Genbank Accession numbers KP067834-KP067885]. Five samples could not be sequenced with at least one of the four primers used and these were not included in the final analysis. Eight samples showed double signals at positions later identified as polymorphic, indicating multiple infec- tions.